Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “PHASE STUDIES”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 163 records · Page 9

Phase I/II Study of Erlotinib Combined With Cisplatin and Radiotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Purpose: Erlotinib, an oral tyrosine kinase inhibitor, is active against head-and-neck squamous cell carcinoma (HNSCC) and possibly has a synergistic interaction with chemotherapy and radiotherapy. We investigated the safety and efficacy of erlotinib added to cisplatin and radiotherapy in locally advanced HNSCC. Methods and Materials: In this Phase I/II trial 100 mg/m{sup 2} of cisplatin was administered on Days 8, 29, and 50, and radiotherapy at 70 Gy was started on Day 8. During Phase I, the erlotinib dose was escalated (50 mg, 100 mg, and 150 mg) in consecutive cohorts of 3 patients, starting on Day 1 and continuing during radiotherapy. Dose-limiting toxicity was defined as any Grade 4 event requiring radiotherapy interruptions. Phase II was initiated 8 weeks after the last Phase I enrollment. Results: The study accrued 9 patients in Phase I and 28 in Phase II; all were evaluable for efficacy and safety. No dose-limiting toxicity occurred in Phase I, and the recommended Phase II dose was 150 mg. The most frequent nonhematologic toxicities were nausea/vomiting, dysphagia, stomatitis, xerostomia and in-field dermatitis, acneiform rash, and diarrhea. Of the 31 patients receiving a 150-mg daily dose of erlotinib, 23 (74%; 95% confidence interval, 56.8%-86.3%) had a complete response, 3 were disease free after salvage surgery, 4 had inoperable residual disease, and 1 died of sepsis during treatment. With a median 37 months' follow-up, the 3-year progression-free and overall survival rates were 61% and 72%, respectively. Conclusions: This combination appears safe, has encouraging activity, and deserves further studies in locally advanced HNSCC.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Phase II Study of Short-Course Radiotherapy Plus Concomitant and Adjuvant Temozolomide in Elderly Patients With Glioblastoma

Purpose: Radiotherapy (RT) and chemotherapy may prolong survival in older patients (age {>=}70 years) with glioblastoma multiforme (GBM), although the survival benefits remain poor. This Phase II multicenter study was designed to evaluate the efficacy and safety of an abbreviated course of RT plus concomitant and adjuvant temozolomide (TMZ) in older patients with GBM. Patients and Methods: Seventy-one eligible patients 70 years of age or older with newly diagnosed GBM and a Karnofsky performance status {>=}60 were treated with a short course of RT (40 Gy in 15 fractions over 3 weeks) plus TMZ at the dosage of 75 mg/m{sup 2} per day followed by 12 cycles of adjuvant TMZ (150-200 mg/m{sup 2} for 5 days during each 28-day cycle). The primary endpoint was overall survival (OS). Secondary endpoints included progression-free survival and toxicity. Results: The Median OS was 12.4 months, and the 1-year and 2-year OS rates were 58% and 20%, respectively. The median and 1-year rates of progression-free survival were 6 months and 20%, respectively. All patients completed the planned programme of RT. Grade 3 or 4 adverse events occurred in 16 patients (22%). Grade 3 and 4 neutropenia and/or thrombocytopenia occurred in 10 patients (15%), leading to the interruption of treatment in 6 patients (8%). Nonhematologic Grade 3 toxicity was rare, and included fatigue in 4 patients and cognitive disability in 1 patient. Conclusions: A combination of an abbreviated course of RT plus concomitant and adjuvant TMZ is well tolerated and may prolong survival in elderly patients with GBM. Future randomized studies need to evaluate the efficacy and toxicity of different schedules of RT in association with chemotherapy.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

A microsecond time resolved x-ray absorption near edge structure synchrotron study of phase transitions in Fe undergoing ramp heating at high pressure

We report a microsecond time-resolved x-ray absorption near edge structure study using synchrotron radiation to dynamically detect structural phase transitions in Fe undergoing rapid heating along a quasi-isochoric path. Within a few ms, we observed two structural phase transitions, which transform the ambient bcc phase of Fe into the fcc phase, and then into the liquid phase. This example illustrates the opportunities offered by energy dispersive x-ray absorption spectroscopy in the study of matter under extreme dynamic conditions. Advanced simulations are compared to these data.

75 CONDENSED MATTER PHYSICS, SUPERCONDUCTIVITY AND↗

X-ray diffraction study of phase transformation dynamics of Fe and Fe-Si alloys along the shock Hugoniot using an x-ray free electron laser

The x-ray free electron laser (XFEL) enables probing a highly compressed material response at the subnanosecond timescale. Here we exploit the ultrafast XFEL pulse to combine reflection x-ray diffraction and laser-driven shock compression to perform a study of the phase transformation and stability in Fe and Fe-Si alloys. Our approach enables us to observe that solid-solid phase transformations occur in Fe and Fe- Si 8.5 wt % in ≤ 130 ps at ~ 130 GPa; no transformation is observed in Fe- Si 16 wt % up to 110 GPa. Density functional theory calculations predict similar phase relations.

36 MATERIALS SCIENCE↗

Macroscopic Hematuria After Conventional or Hypofractionated Radiation Therapy: Results From a Prospective Phase 3 Study

Purpose: To assess the macroscopic hematuria rates within a single-institution randomized phase 3 trial comparing dose-escalated, conventionally fractionated radiation therapy (CFRT) and moderately hypofractionated radiation therapy (MHRT) for localized prostate cancer. Methods and Materials: Patients with intermediate- to high-risk localized prostate cancer were treated with conformal RT and short-course androgen deprivation. Both the prostate and the entire seminal vesicles were treated to 80 Gy in 40 fractions over 8 weeks (CFRT) or 62 Gy in 20 fractions over 5 weeks (MHRT). The endpoint of the present study was the development of any episode or grade of macroscopic hematuria. The median follow-up period was 93 months (range 6-143). Results: Macroscopic hematuria was reported by 25 of 168 patients (14.9%). The actuarial estimate of hematuria at 8 years was 17.0% (95% confidence interval [CI] 10.7%-23.3%). The number of patients with hematuria was 6 and 19 in the CFRT and MHRT arms, respectively, for an actuarial 8-year estimate of 9.7% and 24.3%, respectively (hazard ratio 3.468, 95% CI 1.385-8.684; P=.008). Overall, 8 of 25 patients were found to have biopsy-proven urothelial carcinoma (3 in the CFRT arm and 5 in the MHRT arm; P=.27). Thus, the 8-year actuarial incidence of macroscopic hematuria (after censoring urothelial cancer–related episodes) was 4.1% and 18.2% after CFRT and MHRT, respectively (hazard ratio 4.961, 95% CI 1.426-17.263; P=.012). The results were confirmed by multivariate analysis after accounting for several patient-, treatment-, and tumor-related covariates. Conclusions: MHRT was associated with a statistically significant increased risk of macroscopic hematuria compared with CFRT.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Simultaneous Integrated Boost–Intensity Modulated Radiation Therapy With Concomitant Capecitabine and Mitomycin C for Locally Advanced Anal Carcinoma: A Phase 1 Study

Purpose: Newer radiation techniques, and the application of continuous 5-FU exposure during radiation therapy using oral capecitabine may improve the treatment of anal cancer. This phase 1, dose-finding study assessed the feasibility and efficacy of simultaneous integrated boost–intensity modulated radiation therapy (SIB-IMRT) with concomitant capecitabine and mitomycin C in locally advanced anal cancer, including pharmacokinetic and pharmacogenetic analyses. Methods and Materials: Patients with locally advanced anal carcinoma were treated with SIB-IMRT in 33 daily fractions of 1.8 Gy to the primary tumor and macroscopically involved lymph nodes and 33 fractions of 1.5 Gy electively to the bilateral iliac and inguinal lymph node areas. Patients received a sequential radiation boost dose of 3 × 1.8 Gy on macroscopic residual tumor if this was still present in week 5 of treatment. Mitomycin C 10 mg/m{sup 2} (maximum 15 mg) was administered intravenously on day 1, and capecitabine was given orally in a dose-escalated fashion (500-825 mg/m{sup 2} b.i.d.) on irradiation days, until dose-limiting toxicity emerged in ≥2 of maximally 6 patients. An additional 8 patients were treated at the maximum tolerated dose (MTD). Results: A total of 18 patients were included. The MTD of capecitabine was determined to be 825 mg/m{sup 2} b.i.d. The predominant acute grade ≥3 toxicities included radiation dermatitis (50%), fatigue (22%), and pain (6%). Fifteen patients (83% [95%-CI: 66%-101%]) achieved a complete response, and 3 (17%) patients a partial response. With a median follow-up of 28 months, none of the complete responders, and 2 partial responders had relapsed. Conclusions: SIB-IMRT with concomitant single dose mitomycin C and capecitabine 825 mg/m{sup 2} b.i.d. on irradiation days resulted in an acceptable safety profile, and proved to be a tolerable and effective treatment regimen for locally advanced anal cancer.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Studies on phase formation, microstructure development and elastic properties of reduced NiO-8YSZ anode supported bi-layer half-cell structures of solid oxide fuel cells

Highlights: Black-Right-Pointing-Pointer Detailed study on the development of microstructure and phase in NiO-8YSZ anodes. Black-Right-Pointing-Pointer Detailed study on elastic properties at high temperatures in air/reducing atmosphere. Black-Right-Pointing-Pointer Effects of initial porosity, composition and other issues are evaluated in detail. -- Abstract: Half-cell structures of solid oxide fuel cells (SOFCs) with a thin and dense electrolyte layer of 8YSZ supported by a thick and porous NiO-8YSZ anode precursor structure were reduced in a gas mixture of 5% H{sub 2}-95% Ar at 800 Degree-Sign C for selected time periods in order to fabricate cermets with desired microstructure and composition, and to study their effects on the elastic properties at ambient and reactive atmospheres. It appears that 2 h of exposure to the reducing conditions is enough to reduce {approx}80% of NiO with an enhanced porosity value of 35%. The Ni-8YSZ cermet phase formation in the anode was analyzed with X-ray diffraction (XRD) in correlation with its microstructure. The elastic properties were determined after the reduction, at room and elevated temperatures using the impulse excitation technique. At room temperature the decrease in the Young's modulus was about 44% (after 8 h of reduction) and can be attributed mainly to the changes in the microstructure, particularly the increase in porosity from {approx}12% to 37%. Young's moduli of the as-received precursor and reduced anodes were evaluated as a function of temperature in air and reducing atmosphere. The results were explained in correlation to the initial porosity, composition and oxidation of Ni at the elevated temperatures.

36 MATERIALS SCIENCE↗

Magnetism and magnetocaloric effect in multicomponent Laves-phase compounds: Study and comparative analysis

This paper presents a review and results of comparative study of the influence of Gd on some physical properties of (R{sub 0.9}R′{sub 0.1}){sub 1−x}Gd{sub x}Co{sub 2} solid solutions with R=Dy, Ho and R′=Er, Ho and x varied from 0.05 to 0.15. Powder X-ray diffraction analysis performed at room temperature revealed that all studied solid solutions solidify with the formation of a Laves-phase MgCu{sub 2}-type structure (space group Fd−3m). The magnetization behavior and the magnetic transition are analyzed in terms of the Landau theory. The studies of magnetic properties and heat capacity showed that a relatively small Gd addition significantly increases T{sub C} of the compounds. The maximum percentage increase in T{sub C}, namely, ∼43% was observed for (Ho{sub 0.9}Er{sub 0.1}){sub 1−x}Gd{sub x}Co{sub 2}. However, the highest temperature was noted for the (Dy{sub 0.9}Ho{sub 0.1}){sub 0.85}Gd{sub 0.15}Co{sub 2} solid solution; it is T{sub C}=183.4 K. Below the ordering temperature, all samples are ferrimagnetically ordered; at high temperatures, they are Curie–Weiss paramagnets. Moreover, a small Gd addition eliminates the field-induced magnetic transition near T{sub C} and, as consequence, transforms the nature of magnetic transition from the first- to second-order. The magnetocaloric effect has been estimated in terms of both isothermal magnetic entropy and adiabatic temperature changes. The highest adiabatic temperature change ΔT{sub ad}=3 K and highest isothermal entropy change ΔS{sub mag}=12.1 J/kg K were observed for (Ho{sub 0.9}Er{sub 0.1}){sub 0.95}Gd{sub 0.05}Co{sub 2} at ∼90 K in magnetic fields of 2 T and 3 T, respectively. A decrease in the entropy change has been observed with increasing Gd content in all studied samples. The smallest values of ΔS{sub mag} were observed for the (Dy{sub 0.9}Ho{sub 0.1}){sub 1−x}Gd{sub x}Co{sub 2} solid solutions. Under an external field change of from 0 to 3 T, the maximum entropy change for (Dy{sub 0.9}Ho{sub 0.1}){sub 1−x}Gd{sub x}Co{sub 2} compounds decreases from 6.9 at x=0.05–4.3 J/kg K at x=0.15. The refrigerant capacity for all solid solutions (with 0.05≤x≤0.15) is reported. The effect of increasing Gd content in the solid solutions on their magnetic and magnetocaloric properties is discussed. - Graphical abstract: Temperature dependencies of ΔT{sub ad} induced by µ{sub 0}H=1 and 2 T in (a) (Ho{sub 0.9}Er{sub 0.1}){sub 1−x}Gd{sub x}Co{sub 2} and (b) (Dy{sub 0.9}Er{sub 0.1}){sub 1−x}Gd{sub x}Co{sub 2} solid solutions. Display Omitted.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗

Second random phase approximation studies in metallic clusters

We study collective states in metallic clusters within the second random phase approximation (RPA) including all kinds of couplings among all one particle-one hole and two particle-two hole configurations. The calculations are done in the jellium approximation. The coupling of one particle-one hole configurations with the two particle-two hole ones strongly pushes down the multipole strength distribution, especially for the dipole case, with respect to RPA. The inclusion of the coupling of the two particle-two hole configurations among themselves enhances this behavior also for the collective states whose description within RPA is widely accepted as satisfactory. Some possible origins of these unpleasant results are discussed. In particular, the need for a better treatment of short-range correlations is underlined.

75 CONDENSED MATTER PHYSICS, SUPERCONDUCTIVITY AND↗

Transformation-induced fracture toughening in CuAlBe shape memory alloys: A phase-field study

Stress-induced transformation ahead of a crack tip can relax the stress concentration and produce fracture toughness in shape memory alloys (SMAs). In this manuscript, we utilize a nonisothermal phase-field model (PFM) to study the martensitic transformation induced crack tip toughening in CuAlBe SMA. The force-displacement curve, transformation zone and high stress zone in single crystalline samples show high dependency on the grain orientation with respect to the crack alignment. Comparison between isothermal and non-isothermal simulations reveals that the transformation-induced self-heating decreases the toughening capability by increasing the critical transformation stress. Investigating the high stress zones in CuAlBe and the nontransforming CuAl alloy shows that the toughening is obtained by redistributing the stress concentration far from the crack tip, as the high stress zone follows the tip of the transformation zone. Increasing the acuity of the crack tip is found to generate more symmetric martensite wings on both side of the crack axis and a more localized high stress zone. The polycrystal specimen displays higher toughening due to the internal constraints related to the presence of various grains with difference orientations. Depending on the orientation of the grain inclosing the crack tip, the toughening can be lower or higher. Finally, coincidence of the crack tip with a triple junction is found to improve the toughening behavior.

42 ENGINEERING↗

A phase-field study of stainless-steel oxidation from high-temperature carbon dioxide exposure

An electrochemical phase-field model has been developed to investigate the oxidation mechanisms of the 21-2N valve stainless steel alloy exposed to carbon dioxide at 973 K. Three oxide phases observed in oxidation experiments are included in the model: Mn 3 O 4 , Cr 2 O 3 , and MnCr 2 O 4 . Local charge neutrality and the conserved current condition are assumed to include the impact of the electric potential on oxidation, though it is found to be negligible when the system is electrically isolated. The sensitivity of the oxidation processes to the values of the diffusion mobilities is examined, and the oxidation rate is calibrated against experimental data by modifying the sensitive mobilities. We find that both inward oxygen and outward metal diffusion are important for oxidation. Furthermore, by investigating the impact of the order of the initial oxide layers, we find that Cr 2 O 3 serves as a barrier to outward Mn diffusion. Moreover, controlling the initial oxide layer order can be used to limit oxidation.

36 MATERIALS SCIENCE↗

In-situ high-energy x-ray diffuse-scattering study of the phase transition of Ni{sub 2}MnGa single crystal under high magnetic field.

The defects-related microstructural features connected to the premartensitic and martensitic transition of a Ni{sub 2}MnGa single crystal under a high magnetic field of 50 KOe applied along the [1{bar 1}0] crystallographic direction of the Heusler phase were studied by the in-situ high-energy X-ray diffuse-scattering experiments on the high energy synchrotron beam line 11-ID-C of APS and thermomagnetization measurements. Our experiments show that a magnetic field of 50 KOe applied along the [1{bar 1}0] direction of the parent Heusler phase can promote the premartensitic transition of Ni{sub 2}MnGa single crystal, but puts off martensite transition and the reverse transition. The premartensitic transition temperature (T{sub PM}) increases from 233 to 250 K (-40 to -23 C). The martensite transition start temperature (M{sub s}) decreases from 175 to 172 K (-98 to -101 C), while the reverse transition start temperature (A{sub s}) increases from 186 to 189 K (-87 to -84 C). The high magnetic field leads to a rapid rearrangement of martensite variants below the martensite transition finish temperature (M{sub f}). The real transition process of Ni{sub 2}MnGa single crystal under the high magnetic field was in-situ traced.

43 PARTICLE ACCELERATORS↗

The pressure-induced phase transition studies of In{sub 2}S{sub 3} and In{sub 2}S{sub 3}:Ce nanoparticles

A novel method, gas–liquid phase chemical deposition is developed to prepare In{sub 2}S{sub 3} and In{sub 2}S{sub 3}:Ce nanoparticles. The structural, morphology and composition feature of these two nanoparticles is studied by XRD, HRTEM, and XPS. In situ high-pressure synchrotron X-ray diffraction studies were carried out by using a diamond-anvil cell. The doping does not influence the tetragonal-to-cubic phase transition path while results in a lower phase transition pressure of In{sub 2}S{sub 3}:Ce nanoparticles (4.3 GPa) than that of In{sub 2}S{sub 3} nanoparticles (7.1 GPa). The bulk moduli of tetragonal phases are B{sub 0}=87.1±4.3 GPa and B{sub 0}=55.6±4.1 GPa, respectively. The distinct high-pressure behaviors can be explained in term of the doped ions, causing lattice distortion and reducing structural stability of the In{sub 2}S{sub 3} nanoparticles and further accelerating the phase transition. - Graphical abstract: The phase transition of the In{sub 2}S{sub 3} and In{sub 2}S{sub 3}:Ce nanoparticles have been investigated for the first time by in situ high pressure synchrotron X-ray in a diamond anvil cell. Display Omitted - Highlights: • The high-pressure behaviors of In{sub 2}S{sub 3} and In{sub 2}S{sub 3}:Ce have been investigated. • The pressure-induced tetragonal-to-cubic phase transitions have been observed. • The phase transition pressure of In{sub 2}S{sub 3}:Ce is lower than that of In{sub 2}S{sub 3} nanoparticles. • The distinct high-pressure behaviors are ascribed to the dopants. • The doping causes lattice distortion reducing the structural stability.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗

Study of cerium phase transitions in shock wave experiments

Cerium has a complex phase diagram that is explained by the presence of structural phase transitions. Experiments to measure the sound velocities in cerium by two methods were carried out to determine the onset of cerium melting on the Hugoniot. In the pressure range 4-37 GPa, the sound velocity in cerium samples was measured by the counter release method using manganin-based piezoresistive gauges. In the pressure range 35-140 GPa, the sound velocity in cerium was measured by the overtaking release method using carbogal and tetrachloromethane indicator liquids. The samples were loaded with plane shock wave generators using powerful explosive charges. The onset of cerium melting on the Hugoniot at a pressure of about 13 GPa has been ascertained from the measured elastic longitudinal and bulk sound velocities.

75 CONDENSED MATTER PHYSICS, SUPERCONDUCTIVITY AND↗

Phase 1 Study of Erlotinib Plus Radiation Therapy in Patients With Advanced Cutaneous Squamous Cell Carcinoma

Purpose: To assess the toxicity profile of erlotinib therapy combined with postoperative adjuvant radiation therapy in patients with advanced cutaneous squamous cell carcinoma. Methods and Materials: This was a single-arm, prospective, phase 1 open-label study of erlotinib with radiation therapy to treat 15 patients with advanced cutaneous head-and-neck squamous cell carcinoma. Toxicity data were summarized, and survival was analyzed with the Kaplan-Meier method. Results: The majority of patients were male (87%) and presented with T4 disease (93%). The most common toxicity attributed to erlotinib was a grade 2-3 dermatologic reaction occurring in 100% of the patients, followed by mucositis (87%). Diarrhea occurred in 20% of the patients. The 2-year recurrence rate was 26.7%, and mean time to cancer recurrence was 10.5 months. Two-year overall survival was 65%, and disease-free survival was 60%. Conclusions: Erlotinib and radiation therapy had an acceptable toxicity profile in patients with advanced cutaneous squamous cell carcinoma. The disease-free survival in this cohort was comparable to that in historical controls.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Dose-finding studies in drug development for rare genetic diseases

The small patient populations inherent to rare genetic diseases present many challenges to the traditional drug development paradigm. One major challenge is generating sufficient data in early phase studies to inform dose selection for later phase studies and dose optimization for clinical use of the drug. However, optimizing the benefit-risk profile of drugs through appropriate dose selection during drug development is critical for all drugs, including those being developed to treat rare diseases. Recognizing the challenges of conducting dose finding studies in rare disease populations and the importance of dose selection and optimization for successful drug development, we assessed the dose-finding studies and analyses conducted for drugs recently approved for rare genetic diseases. Of the 40 marketing applications for new molecular entity (NME) drugs and biologics approved by the United States Food and Drug Administration for rare genetic diseases from 2015 to 2020, 21 (53%) of the development programs conducted at least one dedicated dose-finding study. In addition, the majority of drug development programs conducted clinical studies in healthy subjects and included population pharmacokinetic and exposure–response analyses; some programs also conducted clinical studies in patient populations other than the disease for which the drug was initially approved. The majority of primary endpoints utilized in dedicated dose-finding studies were biomarkers, and the primary endpoint of the safety and efficacy study matched the primary endpoint used in the dose finding study in 9 of 13 (69%) drug development programs where primary study endpoints were assessed. Our study showed that NME drug development programs for rare genetic diseases utilize multiple data sources for dosing information, including studies in healthy subjects, population pharmacokinetic analyses, and exposure–response analyses. In addition, our results indicate that biomarkers play a key role in dose-finding studies for rare genetic disease drug development programs. Our findings highlight the need to develop study designs and methods to allow adequate dose-finding efforts within rare disease drug development programs that help overcome the challenges presented by low patient prevalence and other factors. Furthermore, the frequent reliance on biomarkers as endpoints for dose-finding studies underscores the importance of biomarker development in rare diseases.

60 APPLIED LIFE SCIENCES↗

In-situ synchrotron x-ray study of phase transitions in melamine under high pressures and high temperatures

We report a synchrotron energy-dispersive x-ray diffraction study of melamine at high pressure and high temperature. Pressure was generated using a Paris-Edinburgh cell to employ larger sample volumes for weakly scattering organic samples. High temperatures were created using a resistive/graphitic cup surrounding the sample. The PT phase diagram was explored by first pressurizing the sample to 3.5 GPa at room temperature and then heating it up to 1197 K with a concomitant pressure increase to just above 5 GPa. Above 4.85 GPa and 967 K, an irreversible phase transition was observed. Upon cooling the sample, another phase transition was observed which is likely associated with polymerization observed in earlier ex-situ HPHT experiments.

36 MATERIALS SCIENCE↗